To ask the Scottish Executive what the current position is in relation to the development of biotechnology clusters.
In November 1999, Scottish Enterprise launched the "Framework for Action": a four-year £40 million strategy to grow the biotechnology cluster in Scotland.
One year on, the cluster is growing faster than forecast. The number of new biotech companies, support and supply organisations and jobs in the cluster are all ahead of target at this stage. There are now 382 organisations in the Scottish cluster, a presence that is significant in UK and international terms. This is a result of new company creation, the growth of existing businesses and an increase in the number of organisations choosing to participate in the biotechnology cluster.
20 new core biotech companies have been created since March 1999 and provided with vital support from the 11 biotechnology related incubator units across Scotland. Development finance has been provided from a range of sources with Scottish Equity Partners Ltd looking to put together a £75 million fund to invest across technology areas.
Inward investment through LIS has also supported the growth of the cluster, with companies like Organon NV and Serologicals Ltd expanding their operations in Scotland. Global competitiveness has also improved and over the last 18 months STI activities have resulted in a total of £21 million worth of business for Scottish biotech organisations and a further £16 million of projected business in Asian, European and US markets.
Scotland is becoming a world centre of activity in biotechnology. With our excellence in university research, the emergence of Biotech Parks, real success in manufacturing and a highly supportive Economic Development Agency, the biotechnology cluster is progressing towards maturity and self-sufficiency.